Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL

● Sulfacetamide sodium (N-sulfanilylacetamide monosodium salt monohydrate) is a sulfonamide antibacterial agent; sulfonamides are bacteriost

Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL product packaging
Ophthalmic

Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL

● Sulfacetamide sodium (N-sulfanilylacetamide monosodium salt monohydrate) is a sulfonamide antibacterial agent; sulfonamides are bacteriostatic [1][3]
● Inhibits bacterial synthesis of dihydrofolic acid by preventing the condensation of the pteridine with aminobenzoic acid through competitive inhibition of the enzyme dihydropteroate synthetase [1]
● Active against susceptible strains of Escherichia coli, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus (viridans group), Haemophilus influenzae, Klebsiella species and Enterobacter species [1]
● Does not provide adequate coverage against Neisseria species, Serratia marcescens and Pseudomonas aeruginosa; a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs [1]
● Sterile ophthalmic solution, sulfacetamide sodium 15% (150 mg/mL), in 0.4 mL single-dose units [1][2]

Product NameSulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL
Dosage FormOphthalmic
Strength15% (150 mg/mL) 0.4 mL
StandardsBP / ENTERPRISE
Packing10 pics/box
DocumentsCOA, COPP, DMF, CTD Dossiers
MOQContact us for MOQ and current stock
Request Quotation › ← Back to Ophthalmic
WHO Prescribing Guidance

Indications · Administration · Dosage · Precautions

Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.

🎯Indications▾
● Treatment of conjunctivitis and other superficial ocular infections due to susceptible microorganisms, and as an adjunct in systemic sulfonamide therapy of trachoma [1][3] ● Chinese registered product: conjunctivitis, blepharitis and trachoma [2]
💧Administration▾
● For topical ocular use only; instil into the conjunctival sac of the affected eye [1][2] ● Wash hands before use; do not allow the tip of the container to touch the eye, eyelid or any surface, and keep the container tightly closed after use [1][2][4] ● Not for injection [1] ● Do not use if the solution has changed colour or physical state [2]
⚖️Dosage▾
The schedule below refers to registered sulfacetamide sodium eye-drop products of the 15% strength; for the single-dose presentation, instil the volume and frequency prescribed in the approved label of the product concerned [1][2] ● Use exactly as directed; do not use more or less than prescribed [4]
⚠️Precautions & Warnings▾
● Contraindicated in patients with hypersensitivity to sulfonamides or to any ingredient of the preparation [1][2][3] ● Severe sulfonamide reactions (rarely fatal), including Stevens-Johnson syndrome, toxic epidermal necrolysis, fulminant hepatic necrosis, agranulocytosis, aplastic anaemia and other blood dyscrasias — discontinue at the first sign of hypersensitivity, skin rash or any serious reaction [1][3] ● Prolonged use may result in overgrowth of non-susceptible organisms, including fungi; bacterial resistance to sulfonamides may also develop [1][3] ● The effectiveness of sulfonamides may be reduced by para-aminobenzoic acid present in purulent exudates; cross-sensitivity between different sulfonamides may occur [1] ● Discontinue and consult a physician at the first sign of hypersensitivity, increase in purulent discharge, or aggravation of inflammation or pain [1][3] ● Sulfacetamide preparations are incompatible with silver preparations [1] ● Pregnancy (Category C): use only if the potential benefit justifies the potential risk to the fetus — kernicterus may occur in the newborn following oral sulfonamide treatment at term [1][3] ● Breast-feeding: systemically administered sulfonamides can produce kernicterus in infants of lactating women; a decision should be made whether to discontinue nursing or the drug [1][3] ● Paediatric use: safety and effectiveness in children below two months of age have not been established (US reference); the Chinese registered product should be used in children only under adult supervision [1][2][3] ● Adverse reactions: the most frequently reported are local irritation, stinging and burning; less commonly non-specific conjunctivitis, conjunctival hyperemia, secondary infections and allergic reactions; bacterial and fungal corneal ulcers have developed during treatment with sulfonamide ophthalmic preparations [1][3] ● Storage: store at 8–24 °C (10% reference label: 8–25 °C), protect from light; sulfonamide solutions darken on long standing and should be discarded if discoloured (dark brown); Chinese PI — protect from light, keep tightly closed [1][2][3] ● Keep out of the reach of children [3] For full prescribing information, refer to the approved product label / Summary of Product Characteristics of the product concerned [1][2][3][4].

Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.

Why Order From Us

Factory Direct. Fully Documented.

🛡️

GMP Quality

Full batch testing and quality traceability under standard GMP workshops.

🚢

Fast Delivery

Sufficient stock on regular items, familiar with export logistics to 50+ countries.

📑

Registration Support

COA, DMF, dossier and legalization documents for your market registration.

FAQ

Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL — Frequently Asked Questions

Which documents are provided for Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL registration?

Every batch of Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.

What is the MOQ and lead time for Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL?

MOQ and lead time for Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.

Do you support OEM / private label?

Yes. We offer OEM packaging and private-label production for Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL, subject to the regulatory requirements of the destination market.

Which markets have you exported ophthalmic products to?

We have supplied ophthalmic products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.

How is the quality of Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL controlled?

Sulfacetamide Sodium Eye Drops 15% (150 mg/mL) 0.4 mL is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.

Ask About This Product ›
✎ 💬 ↑
👋 Hi! I'm Care, your product guide. Tap me to ask about our medicines & APIs. ×
Care - product guide assistant